CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · IEX Real-Time Price · USD
54.56
-1.65 (-2.94%)
At close: Jul 19, 2024, 4:00 PM
55.90
+1.34 (2.46%)
Pre-market: Jul 22, 2024, 5:20 AM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.63 billion as of July 22, 2024. Its market cap has increased by 8.65% in one year.
Market Cap
4.63B
Enterprise Value
2.75B
1-Year Change
8.65%
Ranking
Category
Stock Price
$54.56
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.63B, an increase of 727.20%. That is a compound annual growth rate of 31.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.63B | -6.83% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merit Medical Systems | 4.97B |
| Select Medical Holdings | 4.95B |
| PACS Group | 4.92B |
| BridgeBio Pharma | 4.90B |
| TransMedics Group | 4.85B |
| Apellis Pharmaceuticals | 4.61B |
| RadNet | 4.58B |
| Haemonetics | 4.52B |